Insider trades
Michael J. LaBarre, Chief Officer of Halozyme Therapeutics HALO, has filed 0 purchases and 50 sales on the open market. The latest trade was on 25/02/27.
Michael J. LaBarre
SVP, Chief Technical Officer
- Company
- Halozyme Therapeutics HALO
- First filing
- 23/01/18
- Trades
- 182 trades
- Buys / sales
- 0 / 50
- 12-month net buying
- No record
- Last trade
- 25/02/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/02/25–25/02/27 | 25/02/27 | 21,697 sh6 trades | $58.10avg. | $1,260,697.25 | −11.1% | |
| Open-market sale10b5-1 plan | 24/10/15–24/10/16 | 24/10/16 | 20,000 sh3 trades | $53.50avg. | $1,070,039.27 | −10.3% | |
| Open-market sale10b5-1 plan | 24/09/17–24/09/18 | 24/09/18 | 20,000 sh3 trades | $62.46avg. | $1,249,105.53 | −10.3% | |
| Open-market sale10b5-1 plan | 24/08/20–24/08/21 | 24/08/21 | 20,000 sh3 trades | $61.40avg. | $1,228,060 | −10.6% | |
| Open-market sale10b5-1 plan | 24/07/23–24/07/24 | 24/07/24 | 20,000 sh3 trades | $55.00avg. | $1,100,085.71 | −10.6% | |
| Open-market sale10b5-1 plan | 24/06/18 | 24/06/20 | 10,000 sh | $49.43 | $494,300 | −5.6% | |
| Open-market sale10b5-1 plan | 24/05/21–24/05/22 | 24/05/22 | 20,000 sh2 trades | $45.27avg. | $905,400 | −10.6% | |
| Open-market sale10b5-1 plan | 24/04/16–24/04/17 | 24/04/17 | 20,000 sh2 trades | $38.42avg. | $768,400 | −10.6% | |
| Open-market sale10b5-1 plan | 24/03/12–24/03/13 | 24/03/13 | 20,000 sh2 trades | $41.96avg. | $839,100 | −11.3% | |
| Open-market sale10b5-1 plan | 24/02/27–24/02/28 | 24/02/28 | 20,000 sh3 trades | $39.75avg. | $794,950.58 | −11.3% | |
| Open-market sale10b5-1 plan | 24/01/16–24/01/17 | 24/01/18 | 20,000 sh2 trades | $36.00avg. | $720,000 | −11.6% | |
| Open-market sale10b5-1 plan | 23/12/12–23/12/13 | 23/12/13 | 20,000 sh3 trades | $40.01avg. | $800,272.27 | −11.6% | |
| Open-market sale10b5-1 plan | 23/11/14–23/11/15 | 23/11/16 | 20,000 sh3 trades | $39.44avg. | $788,700 | −11.6% | |
| Open-market sale10b5-1 plan | 23/10/17 | 23/10/17 | 10,000 sh | $36.52 | $365,200 | −6.2% | |
| Open-market sale10b5-1 plan | 23/09/19 | 23/09/19 | 10,000 sh | $39.10 | $391,000 | −6.2% | |
| Open-market sale10b5-1 plan | 23/08/22 | 23/08/23 | 10,000 sh2 trades | $42.41avg. | $424,100 | −6.2% | |
| Open-market sale10b5-1 plan | 23/07/18 | 23/07/19 | 10,000 sh | $40.43 | $404,300 | −6.6% | |
| Open-market sale10b5-1 plan | 23/06/21 | 23/06/22 | 10,000 sh | $36.00 | $360,000 | −6.6% | |
| Open-market sale10b5-1 plan · Amendment | 23/02/27–23/04/18 | 23/04/19 | 12,984 sh2 trades | $39.11avg. | $507,857.2 | −8.4% | |
| Open-market sale | 23/02/27 | 23/02/28 | 10,000 sh2 trades | $49.55avg. | $495,500 | −6.7% |